
グループ: Randox

カタログの抜粋

EDUCATIONAL GUIDE Meeting ISO 15189:2012 Requirements for MU in the Clinical Laboratory QUALITY CONTROL
カタログの1ページ目を開く
Meeting ISO 15189:2012 Requirements for Measurement Uncertainty in the Clinical Laboratory Measurement Uncertainty (MU) relates to the doubt that exists for the result of any measurement. For every measurement there is always a margin of doubt. In everyday speech, this might be expressed as ‘give or take’. Since there is always a margin of doubt for any measurement, the clinical lab needs to ascertain the width of the margin and the significance of the doubt. Two values are needed in order to quantify uncertainty; the width of the margin or interval, and the confidence level, which states...
カタログの2ページ目を開く
Data Collection Patient sample testing and comparison with a reference value is carried out over time. With this in mind, it is logical that the QC data used to carry out Uncertainty calculation is gathered in a similar fashion - over time. The Australian Association of Clinical Biochemists recommends that at least 6 months of QC data should be used to calculate Uncertainty. In addition to this, Westgard QC maintains that over 100 data points should be used to generate a representative Gaussian distribution of the test system. If 100 repeat measurements were taken in one day by an...
カタログの3ページ目を開く
Other Factors Affecting Uncertainty It is important to consider bias when calculating uncertainty. Bias must be measured and if it is significant removed or minimised. If bias is not removed the uncertainty of the bias correction must be calculated and included in the overall uncertainty measurement. To calculate the uncertainty of bias we must first determine uRef and uRep: uRef – Uncertainty value of the analyte assigned to the reference material/EQA. This can be obtained from the reference material or EQA report. uRep – Uncertainty value of the analyte in the reference material/EQA when...
カタログの4ページ目を開くRandox Laboratories/ランドックスのすべてのカタログと技術パンフレット
-
LT735 Vivalytic Overview
32 ページ
-
Acusera New Controls
8 ページ
-
Acusera 24.7
24 ページ
-
Acusera Third Party Controls
108 ページ
-
Acusera SMART Controls
12 ページ
-
Company Overview
40 ページ
-
Reagents Brochure
64 ページ
-
sdLDL-C
8 ページ
-
RX modena
20 ページ
-
RX misano
20 ページ
-
RX Daytona Plus
20 ページ
-
Rx Imola
20 ページ
-
RX Monaco
20 ページ
-
2024 Product List
64 ページ
-
VeraSTAT-V
16 ページ
-
LT033 RIQAS Explained
64 ページ
-
VERASTAT
16 ページ
-
Endocrine Array
4 ページ
-
Cerebral Arrays
4 ページ
-
Thyroid Arrays
4 ページ
-
Basic QC Stastics
8 ページ
-
Commutability Guide
4 ページ
-
Qnostics
52 ページ
-
Adiponectin LT519
28 ページ
-
Specific Proteins
40 ページ
-
Linearity sets
12 ページ
-
Antioxidants
16 ページ
-
Diabetes Portfolio
28 ページ
-
Total Bile Acids
4 ページ
-
VIVALYTIC
30 ページ
-
RANDOX DISCOVERY
36 ページ
-
HbA1c
2 ページ
-
Preparing QC
1 ページ
-
Point of Care Testing
12 ページ
-
Guide to running QC
1 ページ
-
Tumour Marker Arrays
4 ページ
-
LT169 Cardiac Array
4 ページ
カタログアーカイブ
-
ACUSERA
108 ページ
-
Evidence Evolution
28 ページ
-
Evidence
16 ページ
-
STI Multiplex Array
8 ページ
-
Molecular Testing
16 ページ
-
Evidence Investigator
20 ページ
-
Fertility Array
4 ページ
-
Rx Daytona
16 ページ
-
Evidence Investigator
16 ページ
-
Evidence
16 ページ